|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 35016 |
FusionGeneSummary for SMURF2_NGFR |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SMURF2_NGFR | Fusion gene ID: 35016 | Hgene | Tgene | Gene symbol | SMURF2 | NGFR | Gene ID | 64750 | 4804 |
| Gene name | SMAD specific E3 ubiquitin protein ligase 2 | nerve growth factor receptor | |
| Synonyms | - | CD271|Gp80-LNGFR|TNFRSF16|p75(NTR)|p75NTR | |
| Cytomap | 17q23.3-q24.1 | 17q21.33 | |
| Type of gene | protein-coding | protein-coding | |
| Description | E3 ubiquitin-protein ligase SMURF2E3 ubiquitin ligase SMURF2HECT-type E3 ubiquitin transferase SMURF2SMAD ubiquitination regulatory factor 2hSMURF2 | tumor necrosis factor receptor superfamily member 16NGF receptorTNFR superfamily, member 16low affinity neurotrophin receptor p75NTRlow-affinity nerve growth factor receptorp75 ICD | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q9HAU4 | P08138 | |
| Ensembl transtripts involved in fusion gene | ENST00000262435, ENST00000578200, | ENST00000172229, ENST00000504201, | |
| Fusion gene scores | * DoF score | 10 X 5 X 9=450 | 4 X 2 X 3=24 |
| # samples | 9 | 4 | |
| ** MAII score | log2(9/450*10)=-2.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/24*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: SMURF2 [Title/Abstract] AND NGFR [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | SMURF2 | GO:0006511 | ubiquitin-dependent protein catabolic process | 14755250 |
| Hgene | SMURF2 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 19255252 |
| Hgene | SMURF2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 19122240 |
| Hgene | SMURF2 | GO:1901165 | positive regulation of trophoblast cell migration | 19255252 |
| Tgene | NGFR | GO:0007266 | Rho protein signal transduction | 16712417 |
| Tgene | NGFR | GO:1900182 | positive regulation of protein localization to nucleus | 26268439 |
| Tgene | NGFR | GO:1902895 | positive regulation of pri-miRNA transcription by RNA polymerase II | 26268439 |
| Tgene | NGFR | GO:1904646 | cellular response to amyloid-beta | 11927634 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BRCA | TCGA-AR-A250-01A | SMURF2 | chr17 | 62657947 | - | NGFR | chr17 | 47579425 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000262435 | ENST00000172229 | SMURF2 | chr17 | 62657947 | - | NGFR | chr17 | 47579425 | + |
| 5CDS-5UTR | ENST00000262435 | ENST00000504201 | SMURF2 | chr17 | 62657947 | - | NGFR | chr17 | 47579425 | + |
| intron-3CDS | ENST00000578200 | ENST00000172229 | SMURF2 | chr17 | 62657947 | - | NGFR | chr17 | 47579425 | + |
| intron-5UTR | ENST00000578200 | ENST00000504201 | SMURF2 | chr17 | 62657947 | - | NGFR | chr17 | 47579425 | + |
Top |
FusionProtFeatures for SMURF2_NGFR |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| SMURF2 | NGFR |
| E3 ubiquitin-protein ligase which accepts ubiquitin froman E2 ubiquitin-conjugating enzyme in the form of a thioester andthen directly transfers the ubiquitin to targeted substrates.Interacts with SMAD1 and SMAD7 in order to trigger theirubiquitination and proteasome-dependent degradation. In addition,interaction with SMAD7 activates autocatalytic degradation, whichis prevented by interaction with SCYE1. Forms a stable complexwith the TGF-beta receptor-mediated phosphorylated SMAD2 andSMAD3. In this way, SMAD2 may recruit substrates, such as SNON,for ubiquitin-mediated degradation. Enhances the inhibitoryactivity of SMAD7 and reduces the transcriptional activity ofSMAD2. Coexpression of SMURF2 with SMAD1 results in considerabledecrease in steady-state level of SMAD1 protein and a smallerdecrease of SMAD2 level. {ECO:0000269|PubMed:11389444,ECO:0000269|PubMed:12717440}. | Plays a role in the regulation of the translocation ofGLUT4 to the cell surface in adipocytes and skeletal muscle cellsin response to insulin, probably by regulating RAB31 activity, andthereby contributes to the regulation of insulin-dependent glucoseuptake (By similarity). Low affinity receptor which can bind toNGF, BDNF, NT-3, and NT-4. Can mediate cell survival as well ascell death of neural cells. Necessary for the circadianoscillation of the clock genes ARNTL/BMAL1, PER1, PER2 and NR1D1in the suprachiasmatic nucleus (SCN) of the brain and in liver andof the genes involved in glucose and lipid metabolism in theliver. {ECO:0000250, ECO:0000269|PubMed:14966521,ECO:0000269|PubMed:23785138}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | >NGFR | chr17:62657947 | chr17:47579425 | ENST00000172229 | + | 0 | 6 | 197_248 | 22 | 428 | Compositional bias | Note=Ser/Thr-rich |
| Tgene | >NGFR | chr17:62657947 | chr17:47579425 | ENST00000172229 | + | 0 | 6 | 344_421 | 22 | 428 | Domain | Death |
| Tgene | >NGFR | chr17:62657947 | chr17:47579425 | ENST00000172229 | + | 0 | 6 | 108_146 | 22 | 428 | Repeat | Note=TNFR-Cys 3 |
| Tgene | >NGFR | chr17:62657947 | chr17:47579425 | ENST00000172229 | + | 0 | 6 | 148_188 | 22 | 428 | Repeat | Note=TNFR-Cys 4 |
| Tgene | >NGFR | chr17:62657947 | chr17:47579425 | ENST00000172229 | + | 0 | 6 | 31_64 | 22 | 428 | Repeat | Note=TNFR-Cys 1 |
| Tgene | >NGFR | chr17:62657947 | chr17:47579425 | ENST00000172229 | + | 0 | 6 | 66_107 | 22 | 428 | Repeat | Note=TNFR-Cys 2 |
| Tgene | >NGFR | chr17:62657947 | chr17:47579425 | ENST00000172229 | + | 0 | 6 | 273_427 | 22 | 428 | Topological domain | Cytoplasmic |
| Tgene | >NGFR | chr17:62657947 | chr17:47579425 | ENST00000172229 | + | 0 | 6 | 29_250 | 22 | 428 | Topological domain | Extracellular |
| Tgene | >NGFR | chr17:62657947 | chr17:47579425 | ENST00000172229 | + | 0 | 6 | 251_272 | 22 | 428 | Transmembrane | Helical |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | >SMURF2 | chr17:62657947 | chr17:47579425 | ENST00000262435 | - | 1 | 19 | 157_190 | 17 | 749 | Domain | WW 1 |
| Hgene | >SMURF2 | chr17:62657947 | chr17:47579425 | ENST00000262435 | - | 1 | 19 | 1_98 | 17 | 749 | Domain | C2 |
| Hgene | >SMURF2 | chr17:62657947 | chr17:47579425 | ENST00000262435 | - | 1 | 19 | 414_748 | 17 | 749 | Domain | HECT |
Top |
FusionGeneSequence for SMURF2_NGFR |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_SMURF2_ENST00000262435_chr17_62657947_-_NGFR_ENST00000172229_chr17_47579425_+_423aa MSNPGGRRNGPVKLRLTGVPWRCQGGMPHRPVHTQRXVLQSLQPGRGCGPALWSQPDRVXALPGQRDVLRRGERDRAVQAVHRVRGAPEH VGAVRGGRRRRVPLRLRLLPGXDDWALRGVPRVRGGLGPRVLLPGQAEHRVRGVPRRHVFRRGQPRGPVPALHRVRGHRAPAPRVHTLGR RRVRGDPWPLDYTVHTPRGLGQHSPQHPGAXGTSRTRPHSQHGGRCGDHSDGQLPARGDPRHHRQPHPCLLLHPGCCGCGPCGLHSLQEV EQLQAEQARSQQPASEPDAPTRGRKTPQRQWHLRGQPEPAXPAAPHADSLGPGPQGXRRPLQQPAPSQAGGGGEASQRLCGGHLAAPGGR |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_SMURF2_ENST00000262435_chr17_62657947_-_NGFR_ENST00000172229_chr17_47579425_+_1270nt ATGTCTAACCCCGGAGGCCGGAGGAACGGGCCCGTCAAGCTGCGCCTGACAGGTGTCCCTTGGAGGTGCCAAGGAGGCATGCCCCACAGG CCTGTACACACACAGCGGTGAGTGCTGCAAAGCCTGCAACCTGGGCGAGGGTGTGGCCCAGCCTTGTGGAGCCAACCAGACCGTGTGTGA GCCCTGCCTGGACAGCGTGACGTTCTCCGACGTGGTGAGCGCGACCGAGCCGTGCAAGCCGTGCACCGAGTGCGTGGGGCTCCAGAGCAT GTCGGCGCCGTGCGTGGAGGCCGACGACGCCGTGTGCCGCTGCGCCTACGGCTACTACCAGGATGAGACGACTGGGCGCTGCGAGGCGTG CCGCGTGTGCGAGGCGGGCTCGGGCCTCGTGTTCTCCTGCCAGGACAAGCAGAACACCGTGTGCGAGGAGTGCCCCGACGGCACGTATTC CGACGAGGCCAACCACGTGGACCCGTGCCTGCCCTGCACCGTGTGCGAGGACACCGAGCGCCAGCTCCGCGAGTGCACACGCTGGGCCGA CGCCGAGTGCGAGGAGATCCCTGGCCGTTGGATTACACGGTCCACACCCCCAGAGGGCTCGGACAGCACAGCCCCCAGCACCCAGGAGCC TGAGGCACCTCCAGAACAAGACCTCATAGCCAGCACGGTGGCAGGTGTGGTGACCACAGTGATGGGCAGCTCCCAGCCCGTGGTGACCCG AGGCACCACCGACAACCTCATCCCTGTCTATTGCTCCATCCTGGCTGCTGTGGTTGTGGGCCTTGTGGCCTACATAGCCTTCAAGAGGTG GAACAGCTGCAAGCAGAACAAGCAAGGAGCCAACAGCCGGCCAGTGAACCAGACGCCCCCACCAGAGGGAGAAAAACTCCACAGCGACAG TGGCATCTCCGTGGACAGCCAGAGCCTGCATGACCAGCAGCCCCACACGCAGACAGCCTCGGGCCAGGCCCTCAAGGGTGACGGAGGCCT CTACAGCAGCCTGCCCCCAGCCAAGCGGGAGGAGGTGGAGAAGCTTCTCAACGGCTCTGCGGGGGACACCTGGCGGCACCTGGCGGGCGA GCTGGGCTACCAGCCCGAGCACATAGACTCCTTTACCCATGAGGCCTGCCCCGTTCGCGCCCTGCTTGCAAGCTGGGCCACCCAGGACAG CGCCACACTGGACGCCCTCCTGGCCGCCCTGCGCCGCATCCAGCGAGCCGACCTCGTGGAGAGTCTGTGCAGTGAGTCCACTGCCACATC |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_SMURF2_ENST00000262435_chr17_62657947_-_NGFR_ENST00000172229_chr17_47579425_+_3466nt GGGGAGCTCGGCGTCCCGCTCCCTCCGCGGCTCATGGCGACGACTCTCGGCACATCCGGGACCCTCCGGCCGTGGCGGCCGAGGCGCCGG CTGCTCGGGCCCCAGCCCCGGCCGCTGTGGTGACTCCGCCGCGCCTCGCCGTCGCCCCCGTGCCGCCCGCCGCCCCCGCCGCCCCCGCCG CCGGGGACATGTCTAACCCCGGAGGCCGGAGGAACGGGCCCGTCAAGCTGCGCCTGACAGGTGTCCCTTGGAGGTGCCAAGGAGGCATGC CCCACAGGCCTGTACACACACAGCGGTGAGTGCTGCAAAGCCTGCAACCTGGGCGAGGGTGTGGCCCAGCCTTGTGGAGCCAACCAGACC GTGTGTGAGCCCTGCCTGGACAGCGTGACGTTCTCCGACGTGGTGAGCGCGACCGAGCCGTGCAAGCCGTGCACCGAGTGCGTGGGGCTC CAGAGCATGTCGGCGCCGTGCGTGGAGGCCGACGACGCCGTGTGCCGCTGCGCCTACGGCTACTACCAGGATGAGACGACTGGGCGCTGC GAGGCGTGCCGCGTGTGCGAGGCGGGCTCGGGCCTCGTGTTCTCCTGCCAGGACAAGCAGAACACCGTGTGCGAGGAGTGCCCCGACGGC ACGTATTCCGACGAGGCCAACCACGTGGACCCGTGCCTGCCCTGCACCGTGTGCGAGGACACCGAGCGCCAGCTCCGCGAGTGCACACGC TGGGCCGACGCCGAGTGCGAGGAGATCCCTGGCCGTTGGATTACACGGTCCACACCCCCAGAGGGCTCGGACAGCACAGCCCCCAGCACC CAGGAGCCTGAGGCACCTCCAGAACAAGACCTCATAGCCAGCACGGTGGCAGGTGTGGTGACCACAGTGATGGGCAGCTCCCAGCCCGTG GTGACCCGAGGCACCACCGACAACCTCATCCCTGTCTATTGCTCCATCCTGGCTGCTGTGGTTGTGGGCCTTGTGGCCTACATAGCCTTC AAGAGGTGGAACAGCTGCAAGCAGAACAAGCAAGGAGCCAACAGCCGGCCAGTGAACCAGACGCCCCCACCAGAGGGAGAAAAACTCCAC AGCGACAGTGGCATCTCCGTGGACAGCCAGAGCCTGCATGACCAGCAGCCCCACACGCAGACAGCCTCGGGCCAGGCCCTCAAGGGTGAC GGAGGCCTCTACAGCAGCCTGCCCCCAGCCAAGCGGGAGGAGGTGGAGAAGCTTCTCAACGGCTCTGCGGGGGACACCTGGCGGCACCTG GCGGGCGAGCTGGGCTACCAGCCCGAGCACATAGACTCCTTTACCCATGAGGCCTGCCCCGTTCGCGCCCTGCTTGCAAGCTGGGCCACC CAGGACAGCGCCACACTGGACGCCCTCCTGGCCGCCCTGCGCCGCATCCAGCGAGCCGACCTCGTGGAGAGTCTGTGCAGTGAGTCCACT GCCACATCCCCGGTGTGAGCCCAACCGGGGAGCCCCCGCCCCGCCCCACATTCCGACAACCGATGCTCCAGCCAACCCCTGTGGAGCCCG CACCCCCACCCTTTGGGGGGGGCCCGCCTGGCAGAACTGAGCTCCTCTGGGCAGGACCTCAGAGTCCAGGCCCCAAAACCACAGCCCTGT CAGTGCAGCCCGTGTGGCCCCTTCACTTCTGACCACACTTCCTGTCCAGAGAGAGAAGTGCCCCTGCTGCCTCCCCAACCCTGCCCCTGC CCCGTCACCATCTCAGGCCACCTGCCCCCTTCTCCCACACTGCTAGGTGGGCCAGCCCCTCCCACCACAGCAGGTGTCATATATGGGGGG CCAACACCAGGGATGGTACTAGGGGGAAGTGACAAGGCCCCAGAGACTCAGAGGGAGGAATCGAGGAACCAGAGCCATGGACTCTACACT GTGAACTTGGGGAACAAGGGTGGCATCCCAGTGGCCTCAACCCTCCCTCAGCCCCTCTTGCCCCCCACCCCAGCCTAAGATGAAGAGGAT CGGAGGCTTGTCAGAGCTGGGAGGGGTTTTCGAAGCTCAGCCCACCCCCCTCATTTTGGATATAGGTCAGTGAGGCCCAGGGAGAGGCCA TGATTCGCCCAAAGCCAGACAGCAACGGGGAGGCCAAGTGCAGGCTGGCACCGCCTTCTCTAAATGAGGGGCCTCAGGTTTGCCTGAGGG CGAGGGGAGGGTGGCAGGTGACCTTCTGGGAAATGGCTTGAAGCCAAGTCAGCTTTGCCTTCCACGCTGTCTCCAGACCCCCACCCCTTC CCCACTGCCTGCCCACCCGTGGAGATGGGATGCTTGCCTAGGGCCTGGTCCATGATGGAGTCAGGTTTGGGGTTCGTGGAAAGGGTGCTG CTTCCCTCTGCCTGTCCCTCTCAGGCATGCCTGTGTGACATCAGTGGCATGGCTCCAGTCTGCTGCCCTCCATCCCGACATGGACCCGGA GCTAACACTGGCCCCTAGAATCAGCCTAGGGGTCAGGGACCAAGGACCCCTCACCTTGCAACACACAGACACACGCACACACACACACAG GAGGAGAAATCTCACTTTTCTCCATGAGTTTTTTCTCTTGGGCTGAGACTGGATACTGCCCGGGGCAGCTGCCAGAGAAGCATCGGAGGG AATTGAGGTCTGCTCGGCCGTCTTCACTCGCCCCCGGGTTTGGCGGGCCAAGGACTGCCGACCGAGGCTGGAGCTGGCGTCTGTCTTCAA GGGCTTACACGTGGAGGAATGCTCCCCCATCCTCCCCTTCCCTGCAAACATGGGGTTGGCTGGGCCCAGAAGGTTGTGATGAAGAAAAGT GGGCCAGTGTGGGAATGCGGCAAGAAGGAATTGACTTCGACTGTGACCTGTGGGGATTTCTCCCAGCTCTAGACAACCCTGCAAAGGACT GTTTTTTCCTGAGCTTGGCCAGAAGGGGGCCATGAGGCCTCAGTGGACTTTCCACCCCCTCCCTGGCCTGTTCTGTTTTGCCTGAAGTTG GAGTGAGTGTGGCTCCCCTCTATTTAGCATGACAAGCCCCAGGCAGGCTGTGCGCTGACAACCACCGCTCCCCAGCCCAGGGTTCCCCCA GCCCTGTGGAAGGGACTAGGAGCACTGTAGTAAATGGCAATTCTTTGACCTCAACCTGTGATGAGGGGAGGAAACTCACCTGCTGGCCCC TCACCTGGGCACCTGGGGAGTGGGACAGAGTCTGGGTGTATTTATTTTCCTCCCCAGCAGGTGGGGAGGGGGTTTGGGGGCTTGCAAGTA TGTTTTAGCATGTGTTTGGTTCTGGGGCCCCTTTTTACTCCCCTTGAGCTGAGATGGAACCCTTTTGGCCCCCGAGCTGGGGGCCATGAG CTCCAGACCCCCAGCAACCCTCCTATCACCTCCCCTCCTTGCCTCCTGTGTAATCATTTCTTGGGCCCTCCTGAAACTTACACACAAAAC |
Top |
FusionGenePPI for SMURF2_NGFR |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| SMURF2 | STAMBP, SMAD7, TGFBR1, TGFBR2, SMAD1, SMAD2, SMAD3, SKIL, SMURF1, TRAF2, TNFRSF1B, AIMP1, UBE2L3, NEDD4, SMAD5, SMAD6, RUNX3, RNF11, GSK3B, RHOA, ID1, ID3, KLF5, EGFR, RNF20, AXIN1, SMURF2, SPG20, DAZAP2, RUNX2, RLIM, USP15, CCM2, UBE2D1, UBE2D3, HSPB1, EFNB1, FBXL15, LAPTM5, ACOX3, FLNB, SNRNP70, CANX, TFPI2, DAB2, DGCR2, ARHGAP5, FAM175B, SF3A2, RNF111, TMEM139, TRAF4, TXNIP, ACBD3, CUEDC1, TNPO3, UBC, SMAD4, MRPS22, ILF2, YBX1, ACTA2, SMARCA2, ENAH, MRPS23, MRPS7, MYLK2, RBM14, KCTD12, MRPS31, SLC25A5, ESF1, DNAJC10, UBA52, SLC25A6, MAVS, BTRC, YY1, PTCH1, LATS1, LDLRAD4, UBE2D2, UBE2I, PIAS3, GLIS3, NEDD9, PRMT1, AIMP2, FUBP1, XPO1, NEDD8, SETD7, ITGB1BP1, SEMG2, MARS2, LINGO2, SKI, TOP2A | NGFR | PRKACB, NGF, NDN, NDNL2, FSCN1, MAGED1, TRADD, MAGEH1, CAV1, NGFRAP1, TRAF1, TRAF3, TRAF4, TRAF5, TRAF6, TRAF2, SHC1, TRIM37, TCF19, UFD1L, H2AFX, TK1, CDKN1A, SMN1, STMN2, RCC1, RPN2, TTR, ANXA7, NGFR, BFAR, CD80, SQSTM1, IKBKB, NTRK1, MDM2, TP53 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SMURF2_NGFR |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SMURF2_NGFR |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | NGFR | C0011581 | Depressive disorder | 2 | PSYGENET |
| Tgene | NGFR | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
| Tgene | NGFR | C0011570 | Mental Depression | 1 | PSYGENET |
| Tgene | NGFR | C0027746 | Nerve Degeneration | 1 | CTD_human |
| Tgene | NGFR | C0036341 | Schizophrenia | 1 | PSYGENET |
| Tgene | NGFR | C0036572 | Seizures | 1 | CTD_human |
| Tgene | NGFR | C0524851 | Neurodegenerative Disorders | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|